Onward Medical N.V.
ONWD.BR · BRU
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.11 | 0.13 | 0.45 | 0.11 |
| FCF Yield | -9.80% | -7.39% | -8.48% | -14.60% |
| EV / EBITDA | -8.63 | -11.93 | -9.16 | -5.01 |
| Quality | ||||
| ROIC | -43.26% | -25.46% | -47.97% | -45.55% |
| Gross Margin | -409.03% | -531.17% | -3,112.02% | 1,807.58% |
| Cash Conversion Ratio | 0.89 | 0.97 | 0.81 | 0.82 |
| Growth | ||||
| Revenue 3-Year CAGR | -13.56% | -36.12% | -4.65% | 3.57% |
| Free Cash Flow Growth | -11.43% | -15.21% | -5.82% | 25.03% |
| Safety | ||||
| Net Debt / EBITDA | 1.33 | 2.84 | 0.40 | 0.78 |
| Interest Coverage | -19.49 | -16.24 | 0.00 | -17.82 |
| Efficiency | ||||
| Inventory Turnover | 14.61 | 4.76 | 0.00 | 7.22 |
| Cash Conversion Cycle | -18.92 | 159.08 | -29.90 | -99.85 |